Millie
your market intelligence analyst
Search Results
Edit Save
421 results
DiabetesNews 02/18/2020 12:35
People with maturity-onset diabetes of the young (MODY) can often have reasonable long-term glycemic control without insulin, but MODY diagnosis is difficult because no single commonly used clinical criteria separates it from type 1 or 2 diabetes. With the difference in therapy between type 1 diabetes and MODY, a correct diagnosis of MODY leads to […]
DiabetesNews 02/13/2020 12:20
Ultra-Processed food (UPF) has become widespread in Western cultures in the last century. Ultra-Processed foods include a vast range of food that contains very distinctive nutrient profiles. The French NutriNet-Sante studied 104,707 French adults to assess “the interrelationship between the consumption of Ultra-Processed food and the risk it has on type 2 diabetes.” Read more.
DiabetesNews 02/12/2020 12:15
Rosiglitazone, a drug originally developed to treat type 2 diabetes, was approved by the United States Food and Drug Administration (FDA) in 1999 under the name Avandia. The drug has already been suspended in Europe and restricted in use in the US due to concerns about how it may affect heart health, but the strength […]
DiabetesNews 02/11/2020 12:12
Telemedicine is the use of information and communication technologies, such as the Internet, to help with patient care, and can include diagnosing or even treating the patient. It has already been put to use in treating some chronic conditions, and studies have found telemedicine showed a benefit in helping patients with their blood sugar control. […]
DiabetesNews 02/10/2020 12:06
The US Department of Veterans Affairs (VA) has partnered with Silicon Valley startup Virta Health Corp. to test the popular “Keto” diet. Virtua claims the diet provides treatment “clinically-proven to safely and sustainably reverse type 2 diabetes” without medication or surgery, but some diabetes experts are skeptical and find the company’s partnership with the federal […]
DiabetesNews 02/08/2020 12:40
The FDA recently approved Trijardy XR, a tablet that combines three previously approved medications to treat type 2 diabetes: empagliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, linagliptin, a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin hydrochloride, a biguanide.
DiabetesNews 02/04/2020 12:48
The link between cancer and diabetes is not entirely understood, but biological mechanisms linking diabetes and cancer include hyperglycemia, hyperinsulinemia, oxidative stress, dysregulations of sex hormones, and chronic inflammation. Although there is a known risk for cancer for people with diabetes, routine checks are still absent, and the potential of early detection and treatment of […]
DiabetesNews 02/01/2020 12:40
Plant-based diets have potential benefits in preventing or managing several major chronic diseases such as type 2 diabetes, cardiovascular disease, and cancer by improving insulin sensitivity, blood pressure, and reducing long term weight gain. Plant foods are rich in vitamins, minerals, and antioxidants, and consumption of plant foods helps lower the consumption of red and […]
DiabetesNews 01/29/2020 14:29
The FDA has approved the first oral medication that combines three type 2 diabetes treatments into one pill: the SGLT2 inhibitor empagliflozin, the DPP-IV inhibitor linagliptin and metformin hydrochloride extended release. This triple combination therapy, called Trijardy XR, is approved to lower blood glucose for adults with type 2 diabetes along with diet and exercise. […]

Agribusiness Economics

Business Issues

Companies - Public

Companies - Venture Funded

Agricultural Equipment

Chemicals - Agricultural

Chemicals - Industrial

Commodity Prices

Farm Financial Services

Farming, Forestry, Fisheries

Financial Results

Food and Human Nutrition

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Products - Animal

Products - Forest

Products - Plant

Seeds

Strategic Scenarios

Sources

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications